| A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 Against COVID-19 in Adults (NCT05011526) | Medigen Vaccine Biologics Corp. | 2021-10-08 |
| A Heterologous Prime-boost Study to Evaluate Immunogenicity and Safety of mRNA-1273 With MVC-COV1901 in Adults (NCT05079633) | National Taiwan University Hospital | 2021-09-30 |
| IntraDermal Versus Intramuscular Comirnaty® Efficacy Study (NCT05029245) | Department of Medical Services Ministry of Public Health of Thailand | 2021-08-31 |
| PTX-COVID19-B, an mRNA Humoral Vaccine, Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Demonstrate the Safety, Tolerability, and Immunogenicity of PTX-COVID19-B in Comparison to the Pfizer-BioNTech COVID-19 Vaccine. (NCT05175742) | Providence Therapeutics Holdings Inc. | 2021-08-17 |
| A Study o Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901, CT-COV-21 Sub-study (NCT05038618) | Medigen Vaccine Biologics Corp. | 2021-08-02 |
| A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents (NCT04951388) | Medigen Vaccine Biologics Corp. | 2021-07-22 |
| A Study to Evaluate the Safety, Tolerability, and Immunogenicity of COVID-19 Vaccine, CT-COV-21 Extension Study (NCT05048849) | Medigen Vaccine Biologics Corp. | 2021-07-19 |
| Investigating the Role of 13cis Retinoic Acid in the Treatment of COVID-19 and Enhancement of Its Spike Protein Based Vaccine Efficacy and Safety. (NCT04730895) | Kafrelsheikh University | 2021-07-01 |
| A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adults (NCT04822025) | Medigen Vaccine Biologics Corp. | 2021-05-20 |
| Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease (NCT04818892) | University of Wisconsin, Madison | 2021-03-26 |
| Covid-19 Vaccine Response in Elderly Subjects (NCT04760704) | University Hospital, Lille | 2021-02-18 |
| PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vaccine in Healthy Seronegative Adults Aged 18-64 (NCT04765436) | Providence Therapeutics Holdings Inc. | 2021-01-14 |
| A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult (NCT04695652) | Medigen Vaccine Biologics Corp. | 2020-12-30 |